Revised February 2018
Opioid-Related Overdose Deaths
In 2016, there were 769 opioid-related overdose deaths in Arizona—a rate of 11.4 deaths per 100,000 persons, compared to the national rate of 13.3 deaths per 100,000 persons. From 2013 to 2016, the number of heroin-related deaths increased from 102 to 299 deaths and were the main driver of the rising opioid overdose death rate. In the same period, deaths related to synthetic opioids increased from 36 to 123 deaths.
Opioid Pain Reliever Prescriptions
In 2013, Arizona providers wrote 76.2 opioid prescription for every 100 persons (approximately 5.1 million prescriptions). In the same year, the average U.S. rate was 79.3. Since then, opioid prescriptions in the United States have declined, with a 4.9 percent decline in Arizona from 2013 to 2015, resulting in an estimated 70.5 opioid prescriptions per 100 persons (4.8 million prescriptions) in 2015 (IMS Health, 2016).
Neonatal Abstinence Syndrome (NAS)
The incidence of NAS in Arizona has increased from 1.3 per 1,000 births in 1999 to 3.9 per 1,000 births in 2013, a threefold increase. The average across the 28 states included in the 2013 analysis was 6.0 per 1,000 births (CDC, MMWR, 2014).
HIV Prevalence and HIV Diagnoses Attributed to Injection Drug Use (IDU)
- U.S. Incidence: In 2015, 9.1 percent (3,5941) of the 39,513 new diagnoses of HIV in the United States were attributed to IDU. Among new cases, 8.2 percent (2,6141) of cases among men and 13.2 percent (980) of cases among women were transmitted via IDU (CDC).
- U.S. Prevalence: In 2014, 955,081 Americans were living with a diagnosed HIV infection—a rate of 299.5 per 100,000 persons. Of these, 18.1 percent (131,0561) of males and 22.6 percent (52,013) of females were living with HIV attributed to IDU (CDC).
- State Incidence: Of the new HIV cases in 2015, 717 occurred in Arizona (a rate of 13 per 100,000 persons), with 12.3 percent1 of new cases in males and 21.7 percent of new cases in females attributed to IDU (AIDSVu).
- State Prevalence: In 2014, an estimated 14,726 persons were living with a diagnosed HIV infection in Arizona—a rate of 265 per 100,000 persons. Of these, 18.7 percent1 of males and 27.6 percent of females were living with HIV attributed to IDU (AIDSVu).
Hepatitis C (HCV) Prevalence and HCV Diagnoses Attributed to Injection Drug Use
- U.S. Incidence: In 2015, there were 181,871 reported cases of chronic HCV and 33,900 estimated cases of acute HCV2 (CDC). Where data were available, 64.2 percent of acute cases reported IDU (CDC).
- U.S. Prevalence: An estimated 3.5 million Americans are living with HCV, including approximately 2.7 million living with chronic infections (CDC).
- State Incidence: In 2015, Arizona reported 7,422 cases new of HCV at a rate of 108.9 per 100,000 persons. In a sample of Arizona HCV cases, 67 percent of persons had ever used intravenous drugs (azdhs.gov).
- State Prevalence: As of 2010, an estimated 90,000 persons were living with HCV in Arizona at a rate of 1,890 per 100,000 persons (HepVu).
- Arizona Department of Health Services, Opioid Epidemic
- Centers for Disease Control and Prevention, Opioid Overdose
- Centers for Disease Control and Prevention, Annual Surveillance Report of Drug-Related Risks and Outcomes (2017)
- Substance Abuse and Mental Health Services Administration, Behavioral Health Barometer Arizona, Volume 4 (2017)
- Includes transmission to individuals with injection drug use as a risk factor.
- 2015 estimate after adjusting for under-ascertainment and under-reporting. Data for 2015 were unavailable for Alaska, Arizona, Connecticut, the District of Columbia, Hawaii, Iowa, Mississippi, New Hampshire, Rhode Island, and Wyoming.
Emerging Trends & Alerts
Get more information on Emerging Trends and Alerts, we will update this page with the latest research findings as they develop.
Get this Publication
NIH Addresses the Opioid Crisis
New Opioid Overdose Materials for Patients
Find information about addiction and mental health services in your area. You can search by state or zip code online or call the number.